| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23,8392 | +4,40% | €1,50B | €584,98K | |
SGRY Surgery Partners, Inc. Common Stock | €11,6289 | -1,96% | €1,50B | €1,21M | |
GAB The Gabelli Equity Trust Inc. | €4,8283 | -0,26% | €1,50B | €664,08K | |
HURN Huron Consulting Group Inc. | €90,2360 | -1,74% | €1,49B | €170,69K | |
ENVX Enovix Corporation Common Stock | €7,0807 | -4,64% | €1,49B | €6,28M | |
PAYO Payoneer Global Inc. Common Stock | €4,3802 | -4,95% | €1,49B | €3,99M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8435 | -0,27% | €1,49B | €139,49K | |
STGW Stagwell Inc. Class A Common Stock | €5,6766 | -8,47% | €1,49B | €1,48M | |
CASH Pathward Financial, Inc. Common Stock | €66,9136 | -4,58% | €1,49B | €319,85K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,8024 | -0,25% | €1,49B | €1,07M | |
STRA Strategic Education, Inc. Common Stock | €68,0851 | -0,15% | €1,49B | €152,01K | |
CAPR Capricor Therapeutics Inc | €23,8349 | +1,21% | €1,49B | €572,66K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,3545 | -3,39% | €1,49B | €19,44K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,0549 | -1,68% | €1,49B | €6,49M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21,5350 | +2,97% | €1,49B | €225,25K | |
